R. Martin Chavez

Board Member at Stanford Medicine

R. Martin (“Marty”) Chavez, Ph.D. is a partner and vice chairman of Sixth Street Partners, where he works on research and development; diversity, equity, and inclusion; the sourcing engine; and the More Than Capital business, driving deeper engagement with the portfolio companies. Before joining Sixth Street, Marty served in a variety of senior roles at Goldman Sachs, including Chief Information Officer, where he oversaw the firm’s 9,000 engineers; Chief Financial Officer; and global co-head of the firm’s Securities (now Global Markets) Division. Marty was also a partner and member of the Goldman Sachs management committee.

Marty chairs the Board of Directors of Recursion, a digital biology company industrializing drug discovery by harnessing the power of cloud-based machine learning models. He advises numerous other companies, including block, one, a leading blockchain developer; Cambrian Biopharma, a distributed drug discovery company developing medicines to extend healthy lifespans; Early, which delivers new technologies for identifying and localizing early-stage cancers; and Ketch, which delivers responsive infrastructure for compliance and data security.

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Stanford Medicine

Stanford Medicine improves health through leadership, diversity, and collaborative discoveries and innovation in health care, education, and research. The Stanford School of Medicine is a premier setting for integrated research, medical education, and clinical care. As the academic hub of Stanford Medicine, which also comprises adult and pediatric healthcare delivery systems, it fuels discovery and innovation to advance human health while empowering the medical and scientific leaders of tomorrow. Learn more at med.stanford.edu/school.


Employees

5,001-10,000

Links